MediSpan logo — Pioneering drug data solutions and advanced analytics for ge...

MediSpan

Pioneering drug data solutions and advanced analytics for geriatrics and aging control, supporting healthcare professionals with reliable, secure information.

Founded 2020 Series A Total: $6.50B Health Care, Health and Wellness

General Information

Company Name MediSpan
Founded Year 2020
Industries Health Care, Health and Wellness
Funding Stage Series A
Social

Get notified when MediSpan moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MediSpan

MediSpan is a health-care, medical, and therapeutics company that was founded in 2020. The company is pioneering drug data solutions and advanced analytics for geriatrics and aging control, aiming to support healthcare professionals with reliable, secure information. MediSpan's business model revolves around the GPI, offering reliable and easily loadable data. It prioritizes personal information protection and has measures to ensure its security. Offering an online drug price reference and analytical tool tailored to the stringent needs of healthcare businesses, MediSpan is recognized for its leading drug data solution that merges high-quality content with technology to assist clinicians in making informed decisions. The company recently secured a KRW6.50B Series A investment on 13 May 2021, with investments from DSC Investment, Stassets Investment, and TIGRIS Investment. This investment is a testament to the potential of MediSpan's innovative approach to drug data solutions and analytics in the geriatrics and aging control space.

Taxonomy: healthcare analytics, medical data solutions, geriatrics, aging control, drug development, therapeutics, personal information protection, online drug price reference, clinical decision support, healthcare information security

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A KRW6.50B 3 13 May 2021
Non Equity Assistance Unknown 1 TIPS Program 01 Jul 2020

MediSpan Alternatives & Competitors

MediSpan vs

MPR provides daily drug news, medication safety alerts & recalls, and industry-supported drug inform...

2 employees
MediSpan vs

Delivering precise drug-related information through advanced natural language technology for healthc...

Series Unknown
Health Care, Information Technology
MediSpan vs

Integrated Drug Decision Support Services

66 employees
Data Analytics, Information Technology

FAQ About MediSpan

Pioneering drug data solutions and advanced analytics for geriatrics and aging control, supporting healthcare professionals with reliable, secure information.
MediSpan was founded in 2020.
MediSpan operates in the following industries: Health Care, Health and Wellness.
MediSpan has completed 2 funding rounds, raising a total of $6.50B. The latest funding stage is Series A.
Top alternatives and competitors to MediSpan include MPR - Medical Professionals Reference, Enhanced Medical Decisions, Vademecum A.Ş., PharmCube, AnVil Informatics, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MediSpan and MPR - Medical Professionals Reference are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MediSpan and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy